Skip to main content
logo
Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.78
-0.28 (-4.54%)
Sep 11, 2026, 4:08 PM HKT

HKG:1167 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
738.7353.53155.7163.5295.75152.81
Revenue Growth
1280.17%-65.63%145.13%-33.66%-37.34%-68.58%
Gross Profit
719.9852.93155.713.212.6312.83
Operating Income
519.55-166.24-203.19-411.95-480.93-292.31
Net Income
513.64-145.98-155.71-359.12-371.86-301.19
Earnings Per Share
0.66-0.19-0.20-0.46-0.49-0.40
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,6801,1341,1751,1481,2991,538
Total Debt
159.81165.17152.08209.91147.796.81
Net Cash (Debt)
1,520968.511,022937.931,1511,531
Net Cash Growth
56.97%-5.28%9.01%-18.50%-24.82%-5.32%
Net Cash Per Share
1.961.251.321.211.532.05

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--211.05-74.12-364.2-292.42-147.49
Capital Expenditures
--1.1-12.09-37.83-16.44-10.11
Free Cash Flow
--212.15-86.21-402.03-308.86-157.6
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
97.46%98.89%100.00%5.04%13.20%8.40%
Operating Margin
70.33%-310.59%-130.49%-648.54%-502.29%-191.29%
Pretax Margin
69.53%-272.73%-100.00%-565.36%-388.38%-197.10%
Profit Margin
69.53%-272.73%-100.00%-565.36%-388.38%-197.10%
FCF Margin
--396.35%-55.37%-632.92%-322.58%-103.13%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
5.3184.176.0540.9637.2859.64